Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
AppFolio
APPF
$6.38B
| $349K | ﹤0.01% |
3,319
| – | – |
|
|
PFC
1902
DELISTED
Premier Financial Corp. Common Stock
PFC
| $349K | ﹤0.01% |
12,956
-14,978
| -54% | -$419K |
|
1903
Parsons
PSN
$4.72B
| $349K | ﹤0.01% |
7,553
+2,300
| +44% | +$106K |
|
1904
Diamondrock Hospitality Co
DRH
$2.71B
| $349K | ﹤0.01% |
42,652
-42,654
| -50% | -$371K |
|
1905
World Kinect Corp
WKC
$2.04B
| $349K | ﹤0.01% |
12,767
-12,767
| -50% | -$343K |
|
|
PR
1906
Permian Resources
PR
$17.8B
| $348K | ﹤0.01% |
36,998
-37,004
| -50% | -$354K |
|
|
AGNT
1907
AGNT Inc
AGNT
$666M
| $346K | ﹤0.01% |
31,189
-41,223
| -57% | -$500K |
|
1908
Cannae Holdings
CNNE
$639M
| $345K | ﹤0.01% |
16,710
-16,710
| -50% | -$365K |
|
1909
Arvinas
ARVN
$518M
| $345K | ﹤0.01% |
10,091
+2,800
| +38% | +$118K |
|
1910
Northwest Bancshares
NWBI
$2.3B
| $342K | ﹤0.01% |
24,507
-24,509
| -50% | -$353K |
|
1911
Tanger
SKT
$4.67B
| $342K | ﹤0.01% |
19,060
-19,062
| -50% | -$342K |
|
|
SVFA
1912
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
| $342K | ﹤0.01% |
33,802
-33,800
| -50% | -$339K |
|
1913
Worthington Enterprises
WOR
$2.77B
| $341K | ﹤0.01% |
11,133
| – | – |
|
1914
Pacira BioSciences
PCRX
$1.04B
| $341K | ﹤0.01% |
8,831
+1
| +0% | +$49 |
|
1915
Interparfums
IPAR
$3.99B
| $340K | ﹤0.01% |
3,528
+1
| +0% | +$87 |
|
1916
Revolve Group
RVLV
$1.8B
| $340K | ﹤0.01% |
15,265
-15,845
| -51% | -$380K |
|
1917
Cushman & Wakefield Ltd
CWK
$3.14B
| $339K | ﹤0.01% |
27,251
-27,253
| -50% | -$315K |
|
1918
Helios Technologies
HLIO
$2.57B
| $338K | ﹤0.01% |
6,210
+1
| +0% | +$54 |
|
1919
Methode Electronics
MEI
$496M
| $338K | ﹤0.01% |
7,616
| – | – |
|
1920
Allegro MicroSystems
ALGM
$7.73B
| $336K | ﹤0.01% |
11,182
-11,182
| -50% | -$305K |
|
1921
Vinci Compass Investments Ltd
VINP
$646M
| $335K | ﹤0.01% |
36,910
-36,910
| -50% | -$368K |
|
1922
nCino
NCNO
$2.02B
| $335K | ﹤0.01% |
12,675
-12,673
| -50% | -$357K |
|
1923
Urban Edge Properties
UE
$2.86B
| $335K | ﹤0.01% |
23,752
-23,756
| -50% | -$341K |
|
1924
Vir Biotechnology
VIR
$1.46B
| $334K | ﹤0.01% |
13,194
-13,196
| -50% | -$323K |
|
1925
Valaris
VAL
$5.48B
| $333K | ﹤0.01% |
4,920
-1,000
| -17% | -$62.4K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.